Skip to main content
Year archive

BB Biotech AG — 2023 filings

All 43 regulatory filings released by BB Biotech AG (BION) in 2023, sourced directly from the official regulator.

43 Filings
2023 Period
2023 filings (43)
Filing Released Lang
BB Biotech AG publishes its interim report
Report Publication Announcement 9M 2023
2023-10-20 English
EQS-Adhoc: BB Biotech AG publishes its interim report
Report Publication Announcement
2023-10-20 English
EQS-Adhoc: BB Biotech AG veröffentlicht Zwischenbericht
Report Publication Announcement
2023-10-20 German
EQS-News: BB BIOTECH AG: Biotech equity markets in flux: the impact of rising bond yields and shifting healthcare policies
Report Publication Announcement Q3 2023
2023-10-20 English
EQS-News: BB BIOTECH AG: Biotechnologieaktien im Wandel: Die Auswirkungen steigender Anleiherenditen und sich ändernder Gesundheitspolitik
Report Publication Announcement 9M 2023
2023-10-20 German
Q3 statement / Q3 financial report 2023
Interim / Quarterly Report 9M 2023
2023-10-20 English
BB BIOTECH AG: Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry
Report Publication Announcement H1 2023
2023-07-21 English
EQS-News: BB BIOTECH AG: La rotazione settoriale e i deflussi di capitale pesano sui titoli biotecnologici, ma gli sviluppi positivi permettono alla raccolta di capitali di rafforzare il settore
Report Publication Announcement H1 2023
2023-07-21 Italian
EQS-News: BB BIOTECH AG: Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry
Report Publication Announcement H1 2023
2023-07-21 English
EQS-News: BB BIOTECH AG: Sektorrotation und Kapitalabflüsse belasten Biotechaktien, doch positive Entwicklungen ermöglichen Kapitalbeschaffung zur Stärkung der Industrie
Report Publication Announcement H1 2023
2023-07-21 German
EQS-Adhoc: BB Biotech AG pubblica il proprio rapporto intermedio
Report Publication Announcement
2023-07-21 Italian
EQS-Adhoc: BB Biotech AG publishes its interim report
Report Publication Announcement
2023-07-21 English
EQS-Adhoc: BB Biotech AG veröffentlicht Zwischenbericht
Delisting Announcement
2023-07-21 German
Half-yearly financial report 2023
Interim / Quarterly Report H1 2023
2023-07-21 English
BB BIOTECH AG: Creating blockbuster drugs using algorithms
Regulatory Filings
2023-05-03 English
EQS-News: BB BIOTECH AG: Creating blockbuster drugs using algorithms
Regulatory Filings
2023-05-03 English
EQS-News: BB BIOTECH AG: Mit Algorithmen zu Blockbustern
Investor Presentation
2023-05-03 German
BB Biotech AG publishes its interim report
Report Publication Announcement Q1 2023
2023-04-21 English
EQS-News: BB BIOTECH AG: Primo trimestre sottotono per le aziende biotecnologiche
Earnings Release Q1 2023
2023-04-21 Italian
EQS-News: BB BIOTECH AG: Lackluster first quarter for biotech stocks
Earnings Release Q1 2023
2023-04-21 English
EQS-News: BB BIOTECH AG: Verhaltenes 1. Quartal für Biotechunternehmen
Earnings Release Q1 2023
2023-04-21 German
EQS-Adhoc: BB Biotech AG pubblica il proprio rapporto intermedio
Report Publication Announcement Q1 2023
2023-04-21 Italian
EQS-Adhoc: BB Biotech AG publishes its interim report
Report Publication Announcement Q1 2023
2023-04-21 English
EQS-Adhoc: BB Biotech AG veröffentlicht Zwischenbericht
Report Publication Announcement
2023-04-21 German
Q1 statement / Q1 financial report 2023
Interim / Quarterly Report Q1 2023
2023-04-21 English
Shareholders at BB Biotech AGs AGM vote in favor of all proposals and approve the dividend of CHF 2.85 per share
Notice of Dividend Amount
2023-03-23 English
EQS-News: In occasione dell’Assemblea generale annuale di BB Biotech AG gli azionisti hanno votato a favore di tutte le proposte presentate e approvato il dividendo di CHF 2.85 per azione
Notice of Dividend Amount
2023-03-23 Italian
EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.85 per share
Notice of Dividend Amount
2023-03-23 English
EQS-News: Die Generalversammlung der BB Biotech AG stimmt allen Anträgen zu und genehmigt die Dividende von CHF 2.85 pro Aktie
AGM Information
2023-03-23 German
Edison issues review on BB Biotech (BION)
Report Publication Announcement
2023-03-07 English
BB Biotech AG publishes its 2022 annual report
Report Publication Announcement
2023-02-17 English
EQS-Adhoc: BB Biotech AG pubblica il rapporto annuale 2022
Report Publication Announcement
2023-02-17 Italian
EQS-Adhoc: BB Biotech AG publishes its 2022 annual report
Report Publication Announcement
2023-02-17 English
EQS-Adhoc: BB Biotech AG veröffentlicht Geschäftsbericht 2022
Report Publication Announcement
2023-02-17 German
Annual financial report 2022
Annual Report
2023-02-17 English
Jahresfinanzbericht 2022
Annual Report FY 2022
2023-02-17 German
BB Biotech AG closes the 2022 fiscal year with a loss
Earnings Release FY 2022
2023-01-20 English
EQS-News: BB BIOTECH AG: L’andamento dei mercati azionari biotecnologici riflette la preferenza nel 2022 per le azioni value rispetto a quelle growth – BB Biotech propone la distribuzione di un div...
Earnings Release FY 2022
2023-01-20 Italian
EQS-News: BB BIOTECH AG: Divergent biotech equity markets mirror value over growth theme in 2022 – Proposed dividend of CHF 2.85
Earnings Release FY 2022
2023-01-20 English
EQS-News: BB BIOTECH AG: Uneinheitliche Entwicklung der Biotechaktien spiegeln 2022 die Präferenz von Value gegenüber Wachstum wider – Dividendenvorschlag von CHF 2.85 je Aktie
Notice of Dividend Amount
2023-01-20 German
EQS-Adhoc: BB Biotech AG registra una perdita al termine dell’esercizio 2022
Earnings Release FY 2022
2023-01-20 Italian
EQS-Adhoc: BB Biotech AG closes the 2022 fiscal year with a loss
Earnings Release FY 2022
2023-01-20 English
EQS-Adhoc: BB Biotech AG mit Verlust im Geschäftsjahr 2022
Earnings Release FY 2022
2023-01-20 German